EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A chlorinated diketopiperazine antibiotic targets Mycobacterium tuberculosis

Libang Liang iD, Jeffrey Quigley, Monique Theriault, Akira Iinishi, Rachel Bargabos iD, Madeleine Morrissette, Megan Ghiglieri, Tom Curtis, Rachel Corsetti, Sangkeun Son, Bishwarup Sarkar, Kim Lewis iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.00369-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Libang Liang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Antimicrobial Discovery Center, Northeastern University, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Antitubercular Agents, Diketopiperazines, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We describe a novel macrocyclic peptide, speirobactin, produced by Photorhabdus temperata that selectively kills Mycobacterium tuberculosis . A nonribosomal peptide synthase containing two linear modules codes for the synthesis of speirobactin. The biosynthetic operon contains a pentapeptide-repeat protein as a resistance gene. Genomic analysis of speirobactin-resistant mutants of M. tuberculosis led to the identification of DNA gyrase as the molecular target. The mutations were recreated and show that DNA gyrase is the only target. Transcriptome analysis of M. tuberculosis treated with antibiotics shows that speirobactin clusters close to fluoroquinolones, supporting its action against the DNA gyrase.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisAntitubercular AgentsDiketopiperazinesAnti-Bacterial AgentsMicrobial Sensitivity TestsPeptide SynthasesDNA GyrasePhotorhabdusBacterial ProteinsPeptides, Cyclic

Stichwörter der Autor:innen

DNA gyraseantimicrobial agentsdrug discoverytuberculosis

Substanzen

Peptide SynthasesDNA GyraseAntitubercular AgentsDiketopiperazinesnon-ribosomal peptide synthaseBacterial ProteinsAnti-Bacterial AgentsPeptides, Cyclic

Autor:innen und Institutionen

  • Department of Biology, Antimicrobial Discovery Center, Northeastern University, Boston, Massachusetts, USA.

ORCID-Profile: Libang Liang, Rachel Bargabos, Kim Lewis

Förderung

  • NIAID NIH HHS

Zitieren

APA

Liang, L., Quigley, J., Theriault, M., Iinishi, A., Bargabos, R., Morrissette, M., Ghiglieri, M., Curtis, T., Corsetti, R., Son, S., Sarkar, B., & Lewis, K. (2025). A chlorinated diketopiperazine antibiotic targets Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00369-25

Vancouver

Liang L, Quigley J, Theriault M, Iinishi A, Bargabos R, Morrissette M, et al. A chlorinated diketopiperazine antibiotic targets Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.00369-25

BibTeX
@article{Liang2025,
  author = {Liang, Libang and Quigley, Jeffrey and Theriault, Monique and Iinishi, Akira and Bargabos, Rachel and Morrissette, Madeleine and Ghiglieri, Megan and Curtis, Tom and Corsetti, Rachel and Son, Sangkeun and Sarkar, Bishwarup and Lewis, Kim},
  title = {A chlorinated diketopiperazine antibiotic targets Mycobacterium tuberculosis},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.00369-25}
}
Kostenlos starten →